Moderna announced Monday, June 7, that it had filed for authorization for its vaccine against Covid-19 in adolescents in Canada and in the European Union.
The applications have been filed with the European Medicines Agency (EMA) and Health Canada. Moderna’s vaccine is currently only authorized for people 18 years of age and over. A first vaccine, that of the Pfizer / BioNTech alliance, was authorized at the end of May for adolescents from 12 years old in the 27 countries of the European Union. Pfizer’s vaccine is also already authorized for this age group in Canada.
Moderna announced at the end of May the full results of clinical trials on more than 3,700 participants aged 12 to 17 in the United States. “We are encouraged that Moderna’s Covid-19 vaccine has been shown to be highly effective in preventing Covid-19 in adolescents“, Said Monday the boss of Moderna, Stéphane Bancel, quoted in a press release. The vaccine was “generally well tolerated“, Said the American biotechnology company, with side effects similar to those seen in adults.
The company “also plans to seek emergency use authorization from the United States Drugs Agency (FDA) to extend authorization to use its vaccine to adolescentsIn the United States, Moderna said.